SYNB Putnam BioRevolution ETF
What is SYNB?
SYNB actively invests in companies of all sizes around the globe that enable biological innovation.
SYNB Factset Analytics Insight
SYNB holds a high conviction portfolio that provides exposure to “bio revolution”, which involves technological advancements in the biological and life sciences that contribute to transforming the economy. The fund primarily invests in (i) technology enablers that provide the materials, equipment, and knowledge to enable biological production, (ii) disruptive biotech or synthetic bio companies, and (iii) other firms positioned to benefit from the theme. The fund’s exposure goes beyond healthcare, as it may also invest in other sectors that are likely to be positively impacted, such as consumer discretionary, consumer staples, materials, and agriculture. SYNB's portfolio typically comprises growth stocks. In selecting stocks, the fund manager considers valuation, financial strength, growth potential, industry position, projected future earnings, cash flows, and dividends.
SYNB Portfolio Data
SYNB Index Data
SYNB Portfolio Management
SYNB Tax Exposures
SYNB Fund Structure
Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of SYNB. SYNB is rated a N/A out of 5.
SYNB Sector/Industry Breakdown
SYNB Top 10 Holdings
SYNB Performance Statistics
SYNB Benchmark Comparison Summary
SYNB Benchmark Comparison Market Cap Size
Options Strategies for Outcome Investing
A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security.
A covered call is an income strategy constructed by writing a call option against a holding of the underlying security.